Literature DB >> 11474292

Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies.

C A Iacobuzio-Donahue1, E L Lee, S C Abraham, J H Yardley, T T Wu.   

Abstract

Colchicine is an alkaloid with antimitotic ability used to treat a variety of medical conditions. Colchicine toxicity can result in multiorgan failure and death. The histopathologic features of colchicine toxicity in gastrointestinal biopsies have not been reported. Twenty-one gastrointestinal mucosal biopsies obtained from nine patients receiving oral colchicine therapy were studied. Immunohistochemical staining for Ki67 proliferation antigen was performed, and medical records of each patient were reviewed. All patients had a history of gout. Four patients with chronic renal failure also had clinical evidence of colchicine toxicity, and the other five patients did not. Distinct morphologic changes, seen as metaphase mitoses, epithelial pseudostratification, and loss of polarity, were seen in biopsy material from 4 of 4 (100%) patients with clinical colchicine toxicity. Three of these four cases (75%) also contained abundant crypt apoptotic bodies. These morphologic features were best seen in the biopsies from duodenum and gastric antrum, with relative sparing of the gastric body in the upper gastrointestinal tract. Ki67 staining demonstrated an expansion of the proliferating region in three available cases with clinical colchicine toxicity. These distinctive morphologic features were not seen in the five patients without clinical colchicine toxicity. These results indicate that colchicine toxicity can produce diagnostic morphologic features in gastrointestinal mucosal biopsies. Recognition of these features is important because colchicine toxicity can be fatal if undiagnosed clinically.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474292     DOI: 10.1097/00000478-200108000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Multiple organ failure caused by near-usual doses of colchicine.

Authors:  A Ucgul; T Toptas; M Coskun; H Senturk
Journal:  Ir J Med Sci       Date:  2011-10-20       Impact factor: 1.568

Review 2.  The role of histopathology in forensic practice: an overview.

Authors:  R B Dettmeyer
Journal:  Forensic Sci Med Pathol       Date:  2014-03-01       Impact factor: 2.007

3.  Vomiting, diarrhea, and sudden death with recent southeast asian travel : Fatal colchicine toxicity.

Authors:  Roger W Byard; Peter C Stockham; John D Gilbert
Journal:  Forensic Sci Med Pathol       Date:  2005-06       Impact factor: 2.007

Review 4.  Management of gout in older adults: barriers to optimal control.

Authors:  Karl T Hoskison; Robert L Wortmann
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

6.  OsmoPrep-associated Gastritis: A Histopathologic Mimic of Iron Pill Gastritis and Mucosal Calcinosis.

Authors:  Karen Matsukuma; Dorina Gui; Kristin A Olson; Sooraj Tejaswi; Erica F Clayton; Anne Thai
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

Review 7.  The differential diagnosis of Helicobacter pylori negative gastritis.

Authors:  Hala El-Zimaity; Won-Tak Choi; Gregory Y Lauwers; Robert Riddell
Journal:  Virchows Arch       Date:  2018-09-25       Impact factor: 4.064

8.  Colchicine-associated ring mitosis in liver biopsy and their clinical implications.

Authors:  Anitha Kamath; Wajahat Mehal; Dhanpat Jain
Journal:  J Clin Gastroenterol       Date:  2008-10       Impact factor: 3.062

9.  Olmesartan-associated enteropathy.

Authors:  Vivian S Ebrahim; Jason Martin; Stacey Murthy; Elizabeth Odstrcil; He Huang; Daniel Polter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

10.  Gastric changes following colchicine therapy in patients with FMF.

Authors:  Wael Ismail Al-Daraji; Riham M W Al-Mahmoud; Mohammed Ilyas
Journal:  Dig Dis Sci       Date:  2007-12-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.